FILSPARI Film-coated tablet Ref.[110236] Active ingredients: Sparsentan

Source: European Medicines Agency (EU)  Revision Year: 2024  Publisher: Vifor France, 100–101 Terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris La Défense Cedex, France

Product name and form

Filspari 200 mg film-coated tablets.

Filspari 400 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

Filspari 200 mg film-coated tablets: White to off-white, oval‒shaped, film-coated tablet, debossed with “105” on one side and plain on the other side. The dimensions of the tablets are approximately 13 mm × 7 mm.

Filspari 400 mg film-coated tablets: White to off-white, oval‒shaped, film-coated tablet, debossed with “021” on one side and plain on the other side. The dimensions of the tablets are approximately 18 mm × 8 mm.

Qualitative and quantitative composition

Filspari 200 mg film-coated tablets

Each tablet contains 200 mg of sparsentan.

Excipient with known effect: Each tablet contains 42 mg of lactose.

Filspari 400 mg film-coated tablets

Each tablet contains 400 mg of sparsentan.

Excipient with known effect: Each tablet contains 84 mg of lactose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Sparsentan

Sparsentan is a dual endothelin angiotensin receptor antagonist. It is a single molecule that functions as a high affinity, dual-acting antagonist of both the ETAR and AT1R. Endothelin 1, via ETAR, and angiotensin II, via AT1R, mediate processes that lead to IgAN progression through haemodynamic actions and mesangial cell proliferation, increased expression and activity of proinflammatory and profibrotic mediators, podocyte injury, and oxidative stress. Sparsentan inhibits activation of both ETAR and AT1R and thereby reduces proteinuria and slows the progression of kidney disease.

List of Excipients

Tablet core:

Microcrystalline cellulose
Lactose
Sodium starch glycolate (type A)
Colloidal anhydrous silica
Magnesium stearate

Film coating:

Poly(vinyl alcohol)
Macrogol
Talc
Titanium dioxide (E171)

Pack sizes and marketing

High-density polyethylene (HDPE) bottle with child-resistant polypropylene cap.

Pack size of 30 film-coated tablets.

Marketing authorization holder

Vifor France, 100–101 Terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris La Défense Cedex, France

Marketing authorization dates and numbers

EU/1/23/1788/001
EU/1/23/1788/002

Drugs

Drug Countries
FILSPARI France, Lithuania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.